KMDA Kamada Ltd.
Kamada Ltd is an orphan drug, plasma-derived protein therapeutics company and develops & produces specialty plasma-derived protein therapeutics. Its flagship product include Glassia.
Note: This is not a U.S. company, but they cross-list their shares on a U.S. stock exchange - see the related symbol IT:KMDA.
$6.18
As of 04/14/2021 IEX book CBOE book
Security Information
Category1:
US EquityCategory2:
Common stocksCategory3:
Micro cap
GICS sector: Health Care
Industry: Drug Manufacturers—Specialty &
Index country: Israel
Country of incorporation: Israel
IPO date: 05/31/2013
Outstanding shares: 44,742,963
Average volume: 78,098
Market cap: $269,800,067
Current dividend yield: 0.00%
All SEC filings:
SEC Edgar Online
Annual filings:
20-F
CUSIP: M6240T109
ISIN: IL0010941198
Sedol: B2Q9833
Valuation (See tab for details)
PE ratio: 15.74
PB ratio: 1.51
PS ratio: 2.02
Return on equity: 9.59%
Net income %: 12.86%